Diagnostics & Diseases Market Research Reports & Industry Analysis

... provides granular market segmentation analysis and forecasts for over 40 tumor markers; profiles leading suppliers and recent market entrants with innovative ... 200 Current and Emerging Cancer Diagnostic Tests Oncogenes - Biochemical Markers - Growth Factors - Colony Stimulating Factors - Hormones - Immunohistochemical Stains - Lymphokines ...

... granular market segmentation analysis and forecasts for over 40 tumor markers; profiles leading suppliers and recent market entrants with ... . Over 200 Current and Emerging Cancer Diagnostic Tests Oncogenes - Biochemical Markers - Growth Factors - Colony Stimulating Factors - Hormones - Immunohistochemical ...

... , grouping and infectious disease screening tests in major countries. Countries Analyzed in the Report Armenia, Australia, Austria, Belgium, Bulgaria, Canada, Croatia ... assays. Review of automated and semi- automated molecular and immunohematology analyzers. Technology Review Assessment of current and emerging technologies, and their ...

... decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers. Coagulation Tests Analyzed in the ... characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. ...

... years. New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering ... facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers. Coagulation Tests Analyzed in the Report ...

... regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody ... Instrumentation Review Reviews of current instrumentation technologies, and features of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers. The report ...

... ; compares features of major automated and semi- automated molecular and immunohematology analyzers; profiles leading and emerging competitors; and identifies specific ... typing, grouping and infectious disease NAT screening assays. Review of automated and semi- automated molecular and immunohematology analyzers. Technology Review Assessment ...

... Emerging technologies Review of molecular diagnostic analyzers Specific product and business opportunities for instrument and consumable suppliers Rationale The molecular diagnostics market is unquestionably the ... of leading molecular diagnostic ;analyzers marketed by Abbott, Beckman Coulter, BD, Bio- Rad, Gen- Probe, Roche, Tecan and other suppliers. Extensive review of molecular diagnostic technologies, test ...

... automated microbiology market during the next five years. The report examines key trends; reviews current and emerging assays; analyzes potential ... for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems ...

... microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology ... and Strategic Recommendations Emerging opportunities for new analyzers, reagents kits, IT and other products with ...

... examination of major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs. Review of major analyzers used for infectious disease testing, including their ... technologies and their potential applications for infectious disease testing. Companies developing or marketing infectious disease diagnostic products by individual test. Competitive Assessments Strategic assessments of major suppliers ...

... of major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs. Review of major analyzers used for infectious disease testing, including their ... technologies and their potential applications for infectious disease testing. Companies developing or marketing infectious disease diagnostic products by individual test. Competitive Assessments Strategic assessments of major suppliers ...

... regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests ... Instrumentation Review Reviews of current instrumentation technologies, and features of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers. The report features ...

... Emerging technologies Review of molecular diagnostic analyzers Specific product and business opportunities for instrument and consumable suppliers Rationale The molecular diagnostics market is unquestionably the ... of leading molecular diagnostic ;analyzers marketed by Abbott, Beckman Coulter, BD, Bio- Rad, Gen- Probe, Roche, Tecan and other suppliers. Extensive review of molecular diagnostic technologies, test ...

... analyzers; profiles key competitors; and identifies specific product and marketing opportunities for reagent and instrument suppliers. Rationale Clinical chemistry and immunodiagnostic ... chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and feature comparison of high- , medium- , and low- volume/POC analyzers. Technology Review ...

... cancer diagnostic testing. Review of competing/complementing technologies. Companies, universities and research centers developing new cancer diagnostic tests ...

... their potential applications for cancer diagnostic testing. Review of competing/complementing technologies. Companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Strategies Strategic assessments of major suppliers and start- up firms developing innovative cancer diagnostic technologies and ...

... ; compares features of major automated and semi- automated molecular and immunohematology analyzers; profiles leading and emerging competitors; and identifies specific product ... typing, grouping and infectious disease NAT screening assays. Review of automated and semi- automated molecular and immunohematology analyzers. Technology Review Assessment of current ...

The Global In Vitro Diagnostic Industry Analysis & Forecast Report 2016-2021 is a professional and in-depth study on the current state of the In Vitro Diagnostic industry. The report analysis the global market of In Vitro Diagnostic by main manufactures and geographic regions. The report includes In Vitro Diagnostic definitions, product ...

This New Version In Vitro Diagnostics (IVD) Market Research Report is a deep market research report in this ...

U.S. clinical oncology next generation sequencing market is anticipated to reach USD 1.53 billion by 2024, according to a new report by Grand View Research, Inc. Application of NGS platform for clinical oncology are ...

... Global Capillary Blood Collection Tubes Market Research Report 2016 is a valuable source of insightful data for business strategists. It provides the Capillary Blood Collection Tubes industry overview with growth ...

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of ...

... the growth of oncology biosimilars market. The Global Oncology Biosimilars Market Research Report 2016 is a valuable source of insightful data for business strategists. It provides the Oncology Biosimilars industry overview with ... GlaxoSmithKline (GSK) Merck Sanofi and Sandoz. Global Oncology Biosimilars Market: Product Segment Analysis Type I Type II Type III Global Oncology Biosimilars Market: Application Segment Analysis Application I Application ...

The global oncology biosimilars market will witness substantial growth over the forecast period and is ... drivers promoting the growth of oncology biosimilars market. The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical ...

2016 Global Hormone Refractory Breast Cancer Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Hormone Refractory Breast Cancer industry, focusing on the ... with: 1.) basic information; 2.) the Asia Hormone Refractory Breast Cancer industry; 3.) the North American Hormone Refractory Breast Cancer industry; 4.) the European Hormone Refractory Breast Cancer industry; 5.) market entry and investment feasibility ...

2016 Global Oncology Consult Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Oncology Consult industry, focusing on the main ... with: 1.) basic information; 2.) the Asia Oncology Consult industry; 3.) the North American Oncology Consult industry; 4.) the European Oncology Consult industry; 5.) market entry and investment feasibility; and ...

This New Version Body Composition Analyzers Market Research Report is a deep market research report in this market. ... in Chapter 2. Then the global and regional market is analyzed. In these chapters, this report analyzed major market data like capacity, production, capacity ...

... molecular diagnostics market: HPV and CT/NG. The report “Global Molecular Diagnostics Market - Focus on Infectious Diseases (HPV/Chlamydia/Gonorrhea) & Genetic Testing (HLA) - Industry Outlook 2022” provides an in-depth analysis of global molecular diagnostics market ...

... molecular diagnostics market: HPV and CT/NG. The report “Global Molecular Diagnostics Market - Focus on Infectious Diseases (HPV/Chlamydia/Gonorrhea) & Genetic Testing (HLA) - Industry Outlook 2022” provides an in-depth analysis of global molecular diagnostics market ...

... low-volume/POC in vitro diagnostic systems within the following market segments: Blood Typing, Grouping, and Screening Cancer Diagnostic Clinical Chemistry and Immunodiagnostics Coagulation Testing Hematology and Flow Cytometry Microbiology Molecular Diagnostics Contains 170 pages

... expiry of blockbuster cancer drugs is another major factor which is propelling the growth of the cancer generics industry. As per RNCOS report “Global Cancer Generics Market Forecast to 2022”, the global cancer generics market is anticipated ... widely used type of cancer generics drugs. The report also highlights the major cancer generic drugs available in the global market. Furthermore, the global cancer generics market has also been ...

... report from VPGMarketResearch.com provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution ...

... 394 pages, 28 tables, and presents a comprehensive analysis of the Italian hospital hemostasis diagnostic testing market, including: Major issues pertaining to the Italian coagulation ... . Volume and sales forecasts for 40 coagulation procedures performed in Italian hospitals, including typical coagulation daily work loads. Review of current instrumentation ...

... 392 pages, 28 tables, and presents a comprehensive analysis of the Japanese hospital hemostasis diagnostic testing market, including: Major issues pertaining to the Japanese coagulation ... . Volume and sales forecasts for 40 coagulation procedures performed in Japanese hospitals, including typical coagulation daily work loads. Review of current instrumentation ...

... 390 pages, 28 tables, and presents a comprehensive analysis of the Spanish hospital hemostasis diagnostic testing market, including: Major issues pertaining to the Spanish coagulation ... . Volume and sales forecasts for 40 coagulation procedures performed in Spanish hospitals, including typical coagulation daily work loads. Review of current instrumentation ...

... of emerging in vitro diagnostic technologies and their potential applications within the following market segments: Blood Typing, Grouping, and Screening Cancer Diagnostics Clinical Chemistry ... of current and emerging suppliers of in vitro diagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products ...

... of emerging in vitro diagnostic technologies and their potential applications within the following market segments: Blood Typing, Grouping, and Screening Cancer Diagnostics Clinical Chemistry and Immunodiagnostics Coagulation Testing Hematology and Flow Cytometry Microbiology Molecular Diagnostics Technologies analyzed in the ...

... segments? Will the industry consolidate, decentralize, or undergo a bimodal transformation? What will be the impact on purchasing influences, marketing strategies, joint ventures ...

... low-volume/POC in vitro diagnostic systems within the following market segments: Blood Typing, Grouping, and Screening Cancer Diagnostics Clinical Chemistry and ... Flow Cytometry Microbiology Molecular Diagnostics The report also presents strategic assessments of current and emerging suppliers of in vitro diagnostic products, including their sales ...

... a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as test volume and sales forecasts by country. The report also presents strategic profiles of current and emerging suppliers of molecular diagnostic products in terms of their sales, product portfolios, marketing ...

The report presents insightful analyses of major current and emerging suppliers of molecular diagnostic products in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Contains 120 pages

... and market share estimates for major suppliers of molecular diagnostic products by country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics ...

This market report gives a comprehensive and easy-to-review analysis of the liquid biopsy market 2016 – 2020. It provides key market data and identifies new and emerging ... on their current liquid biopsy practices and their plans over the next three. Its findings provide a wealth of market information on the liquid biopsy market and enables ...

... a comprehensive and easy-to-review analysis of the molecular diagnostics market for the period 2016 -2020. The report provides key market information and identifies new ... augments the detailed market findings presented in the PDF report, allowing rapid and easy in-depth analysis across all molecular diagnostics markets. This database can ...

... , the Global Cancer Vaccines market is accounted for $2.25 billion in 2015 and is expected to reach $10.00 billion by 2022 growing at a CAGR of 23.7%. Factors such as rising number of cancer patients ... organisation and GAVI initiatives. Some of the key players in Global Cancer Vaccines market include Oxford BioMedica, Vaccinogen Inc., GlaxoSmithKline, Sanofi India Limited ...

... sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Prostate Cancer’s incident population. Identify sub-populations within Prostate Cancer which require treatment ...

... “Global Cancer Diagnostic Market with Focus on Lung and Breast Cancer (2016-2020)”, provides analysis of the global cancer diagnostics market and the US cancer diagnostics market, with detailed analysis of market size and growth, penetration and market share. The report also provides the analysis of the global and ...

... with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). Some say novel therapies ... to evolve over the next five years in KOL Insight: Colorectal Cancer. You’ll get 12 North American and European KOLs’ candid thoughts on 6 recently marketed CRC treatments ...

According to Stratistics MRC, the Global Cancer Biomarkers market is estimated at $9215.32 million in 2015 and is expected to reach $20958.63 million by ... opportunity for the market growth. North America captured huge share in terms of revenue owing to raising awareness towards cancer diagnostics. However, Asia ...